The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized phase 2 trial of flexible and extended dosing of 177Lu-PSMA-617 molecular radioligand therapy in mCRPC (FLEX-MRT): Trial in progress update.
 
Adrien Holzgreve
Consulting or Advisory Role - ABX Advanced biochemical compounds
Research Funding - ABX Advanced biochemical compounds (Inst)
 
Astrid Delker
No Relationships to Disclose
 
Zachary Ells
No Relationships to Disclose
 
Julia Brosch-Lenz
No Relationships to Disclose
 
Lena Unterrainer
Honoraria - Astellas Pharma; Novartis
Consulting or Advisory Role - Telix Pharmaceuticals
Research Funding - ABX advanced biochemical compounds. (Inst)
 
John Nikitas
No Relationships to Disclose
 
Shaojun Zhu
Consulting or Advisory Role - AdvanCell isotopes; Freshwind Biotech; SOFIE
 
Maria Contreras
No Relationships to Disclose
 
Hamzah Alam
No Relationships to Disclose
 
Rejah Nabong
No Relationships to Disclose
 
Stephanie Lira
No Relationships to Disclose
 
Arseniy Vasilyev
No Relationships to Disclose
 
Lillian Chen
No Relationships to Disclose
 
Tristan Grogan
No Relationships to Disclose
 
David Elashoff
No Relationships to Disclose
 
Catherine Meyer
No Relationships to Disclose
 
Magnus Dahlbom
No Relationships to Disclose
 
Johannes Czernin
Leadership - SOFIE; Trethera
Stock and Other Ownership Interests - SOFIE; Trethera
Consulting or Advisory Role - Aktis Oncology; RayzeBio
 
Jeremie Calais
Honoraria - Advanced Accelerator Applications; Curium Pharma; EXINI Diagnostics; Novartis; Progenics; Radiomedix
Consulting or Advisory Role - Amgen; Astellas Pharma; Bayer; Blue Earth Diagnostics; Curium Pharma; GE Healthcare; Janssen; Lantheus Medical Imaging; Novartis; POINT Biopharma; Progenics; Radiomedix; Sanofi; SOFIE; Telix Pharmaceuticals
Speakers' Bureau - Lantheus Medical Imaging
Research Funding - Progenics